Assistant Professor, Ob/Gyn and Reproductive Science, University of Pittsburgh School of Medicine
Obstetrics & Gynecology
Dr. Paniti Sukumvanich, MD
|
|
Give Review
Dr. Paniti Sukumvanich works in the field of Obstetrics & Gynecology. He graduated from University at Buffalo, School of Medicine and Biomedical Sciences. He over the years received 1 awards: "Fellow (FACOG)". Paniti Sukumvanich is a published MD. He published 39 publications, including: 'Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.' Doctor Paniti Sukumvanich, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous Carcinoma: a National Cancer Database study.
- MRI-guided high-dose-rate intracavitary brachytherapy for treatment of Cervical cancer: the University of Pittsburgh experience.
- Patterns of care for omission of radiation therapy for elderly women with early-stage breast Cancer receiving hormonal therapy.
- USA Endometrial Cancer Projections to 2030: should we be concerned?
- Improvement in Symptom Burden Within One Day After Palliative Care Consultation in a Cohort of Gynecologic Oncology Inpatients.
- Patterns of care and brachytherapy boost utilization for vaginal Cancer in the United States.
- Adoption and impact of concurrent chemoradiation therapy for vaginal Cancer: A National Cancer Data Base (NCDB) study.
- Extended Field Intensity Modulated Radiation Therapy With Concomitant Boost for Lymph Node-Positive Cervical Cancer: Analysis of Regional Control and Recurrence Patter...
- National Cancer Data Base Analysis of Radiation Therapy Consolidation Modality for Cervical Cancer: The Impact of New Technological Advancements.
- Neoadjuvant radiotherapy with or without chemotherapy followed by extrafascial hysterectomy for locally advanced endometrial Cancer clinically extending to the cervix ...
- Predictors of palliative care consultation on an inpatient gynecologic oncology service: Are we following ASCO recommendations?
- Impact of facility volume on therapy and survival for locally advanced Cervical cancer.
- The risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial Cancers.
- Preoperative Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Vulvar Carcinoma: Analysis of Pattern of Relapse.
- Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian Carcinoma during the drug shortage era.
- Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity.
- The role of sentinel lymph node biopsy in Paget's disease of the breast.
- Sentinel lymph node biopsy in early-stage Cervical cancer: utility of intraoperative versus postoperative assessment.
- Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of Cervical cancer using a hybrid magnetic resonance imaging/computed tomog...
- Cellular localization of activated N-WASP using a conformation-sensitive antibody.
- Ultrasound for the detection of intraperitoneal fluid: the role of Trendelenburg positioning.
- Surgery Versus Radiation Therapy for Stage IB2 Cervical Carcinoma: A Population-Based Analysis.
- Possible use of CA-125 level normalization after the third chemotherapy cycle in deciding on chemotherapy regimen in patients with epithelial ovarian Cancer: brief rep...
- Review of current treatment options for pregnancy-associated breast Cancer.
- Intraperitoneal catheter leads to prolongation of the time to normalization of serum CA125 levels.
- Incidence and time course of bleeding after long-term amenorrhea after breast Cancer treatment: a prospective study.
- Does the number of nodes removed impact survival in vulvar Cancer patients with node-negative disease?
- Definitive radiation therapy for endometrial Cancer in medically inoperable elderly patients.
- Completion of intraperitoneal chemotherapy in advanced ovarian Cancer and catheter-related complications.
- Practice patterns of intraperitoneal chemotherapy in women with ovarian Cancer.
- Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar Carcinoma.
- High-dose rate brachytherapy (HDRB) for primary or recurrent Cancer in the vagina.
- High-dose-rate Rotte "Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial Cancer: 10-year results.
- Survival for stage IB Cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy.
- Serum CA125 predicts extraUterine disease and survival in Uterine carcinosarcoma.
- Incidence, time course, and determinants of menstrual bleeding after breast Cancer treatment: a prospective study.
- Total Pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003).
- Recurrent small cell lung Cancer presenting as bilateral adnexal masses.
Schools
State University of New York At Buffalo
Magee WomenS Hospital
University Of Pittsburgh Med Center
Procedures Preformed
- Colporrhaphy
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- Endometriosis
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACOG)
Education
-
University of Pittsburgh Medical Center -
University at Buffalo, School of Medicine and Biomedical Sciences
Hospital
-
UPMC Passavant -
UPMC Presbyterian Shadyside
Drug Facts
| NPI NUMBER | 1356316210 | |
| NPPES Provider LastName | SUKUMVANICH | |
| NPPES Provider FirstName | PANITI | |
| NPPES Provider ZIPCode | 152133108 | |
| NPPES Provider State | PA | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 226.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 15.0 | |
| Percent Opioid Claims | 6.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356316210 |
| Last Name Of The Provider | SUKUMVANICH |
| First Name Of The Provider | PANITI |
| View All |
Similar Doctors
|
|
Dr. Jan C. Seski, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James A. Crozier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan J. Kunschner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander B. Olawaiye, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John T. Comerci Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carol A. Krupski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard W. Hemphill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eileen M. Segreti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Beverly A. Jaramillo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aurora M. Miranda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brinda N. Kalro, MD
This Doctor is OpenDoctor Recommended.
|